Veracyte (VCYT)
$
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
Key Insights
Critical company metrics and information
Total Outstanding Shares
76.45 Million SharesDividend
No dividendSIC Description
Services-medical Laboratories
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Cash Flow Statement
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Net Cash Flow From Financing Activities, Continuing | $10.06 Million |
| Net Cash Flow From Operating Activities, Continuing | $66.12 Million |
| Net Cash Flow, Continuing | $71.55 Million |
| Net Cash Flow From Investing Activities | $-4.63 Million |
| Exchange Gains/Losses | $274000.00 |
| Net Cash Flow From Financing Activities | $10.06 Million |
| Net Cash Flow From Investing Activities, Continuing | $-4.63 Million |
| Net Cash Flow | $71.83 Million |
| Net Cash Flow From Operating Activities | $66.12 Million |
Income Statement
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Income/Loss From Continuing Operations After Tax | $-9.27 Million |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Operating Expenses | $439.09 Million |
| Net Income/Loss Available To Common Stockholders, Basic | $-9.27 Million |
| Other Operating Expenses | $370.41 Million |
| Basic Earnings Per Share | $0.13 |
| Benefits Costs and Expenses | $433.50 Million |
| Income Tax Expense/Benefit | $1.10 Million |
| Diluted Earnings Per Share | $0.13 |
| Net Income/Loss Attributable To Parent | $-9.27 Million |
| Costs And Expenses | $439.09 Million |
| Diluted Average Shares | $77.50 Million |
| Net Income/Loss | $-9.27 Million |
| Research and Development | $68.68 Million |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Income/Loss From Continuing Operations Before Tax | $-8.17 Million |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Revenues | $425.33 Million |
| Basic Average Shares | $76.26 Million |
| Operating Income/Loss | $-23.54 Million |
Balance Sheet
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Current Assets | $356.85 Million |
| Other Non-current Assets | $809.29 Million |
| Liabilities And Equity | $1.28 Billion |
| Equity Attributable To Parent | $1.18 Billion |
| Liabilities | $98.98 Million |
| Noncurrent Liabilities | $28.67 Million |
| Wages | $30.74 Million |
| Noncurrent Assets | $918.17 Million |
| Intangible Assets | $108.87 Million |
| Other Current Assets | $336.49 Million |
| Assets | $1.28 Billion |
| Current Liabilities | $70.31 Million |
| Accounts Payable | $9.67 Million |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity | $1.18 Billion |
| Other Current Liabilities | $29.90 Million |
| Inventory | $20.36 Million |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
ⓒ 2024 Financhle. All Rights Reserved.